Stalfort John A III

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$3.06M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Stalfort John A III

According to the SEC Form 4 filings, Stalfort John A III, being in a position of

  1. director at Verrica Pharmaceuticals Inc.,
    оver the last 12 months, has bought 1123595 shares for $1,000,000, and sold 0 shares,
    over all time since 2019-01-07, has bought 1402161 share for $1.8M, and sold 0 shares.

The largest purchase of all time was on 2024-11-22 and amounted to 1123595 shares of Verrica Pharmaceuticals Inc. for $1,000,000.

Biography of Stalfort John A III

No biography is available at this moment.

2024-11-22PurchaseVerrica Pharmaceuticals Inc.
VRCA
director
1.12M
2.212%
$0.89$1,000,000-0.35%
2023-08-16PurchaseTaysha Gene Therapies, Inc.
TSHA
director
777,778
0.5651%
$0.90$700,000+21.5%
2022-07-05PurchaseVerrica Pharmaceuticals Inc.
VRCA
238,095
0.4962%
$2.10$500,000+61.6%
2021-07-06PurchaseAcumen Pharmaceuticals, Inc.
ABOS
director
35,000
0.0724%
$16.00$560,000-67.95%
2020-08-14PurchaseVerrica Pharmaceuticals Inc.
VRCA
director
15,700
0.0612%
$6.38$100,166+69.47%
2020-08-13PurchaseVerrica Pharmaceuticals Inc.
VRCA
director
15,550
0.064%
$6.45$100,298+77.03%
2019-01-07PurchaseVerrica Pharmaceuticals Inc.
VRCA
director
9,221
0.0336%
$10.45$96,386-2.47%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.